World Journal of Dentistry

Register      Login

VOLUME 15 , ISSUE 2 ( February, 2024 ) > List of Articles


Evaluation of Different Pulpotomy Agents Used for Treatment of Immature Permanent Molars: A Randomized Clinical Trial

Mahmoud M Badran, Salwa M Awad, Rizk A Elagamy

Keywords : Biodentine, Calcium hydroxide, Immature permanent teeth, Platelet-rich fibrin, Randomized clinical trial

Citation Information : Badran MM, Awad SM, Elagamy RA. Evaluation of Different Pulpotomy Agents Used for Treatment of Immature Permanent Molars: A Randomized Clinical Trial. World J Dent 2024; 15 (2):133-140.

DOI: 10.5005/jp-journals-10015-2380

License: CC BY-NC 4.0

Published Online: 02-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Aim: The present study was performed to assess and compare the effectiveness of pulpotomy agents, namely calcium hydroxide, biodentine, and platelet-rich fibrin (PRF), in the treatment of immature permanent molars in children aged 7–10 years. Materials and methods: A total of 28 children (45 molars) who underwent pulpotomy were assigned at random to one of three groups—calcium hydroxide, biodentine, or PRF. At 3, 6, 9, 12, and 18 months, postoperatively, the patients underwent clinical and preoperative radiographic evaluations utilizing digital periapical radiography and cone beam computed tomography (CBCT). Results: There were no statistically significant changes observed in any of the groups during the 18-month follow-up period. At 18 months, the clinical success rates for calcium hydroxide, biodentine, and PRF were 86.7, 100, and 93.3%, respectively. Radiographic analysis of the root lengths of the three groups did not identify any significant variations that were statistically significant. Conclusion: Both biodentine and PRF can be considered a substitute for calcium hydroxide as pulp medicaments after pulpotomy of immature permanent molars. Clinical significance: The clue for the future about treating permanent molars with immature roots. It is recommended to use PRF as a great oral tissue-derived stem cell substitute for calcium hydroxide.

PDF Share
  1. Zacher A, Manfra Marretta S. Decision-making and management of immature permanent teeth with crown fractures in small animals—a review. J Vet Dent 2021;38(2):81–92. DOI: 10.1177/08987564211046325
  2. Neha K, Kansal R, Garg P, et al. Management of immature teeth by dentin-pulp regeneration: a recent approach. Med Oral Patol Oral Cir Bucal 2011;16(7):e997–1004. DOI: 10.4317/medoral.17187
  3. Palczewska-Komsa M, Kaczor-Wiankowska K, Nowicka A. New bioactive calcium silicate cement mineral trioxide aggregate repair high plasticity (MTA HP)—a systematic review. Materials 2021;14(16):4573. DOI: 10.3390/ma14164573
  4. Malkondu Ö, Kazandağ MK, Kazazoğlu E. A review on biodentine, a contemporary dentine replacement and repair material. BioMed Res Int 2014;2014:160951. DOI: 10.1155/2014/160951
  5. Borie E, Oliví DG, Orsi IA, et al. Platelet-rich fibrin application in dentistry: a literature review. Int J Clin Exp Med 2015;8(5):7922–7929.
  6. Jayadevan V, Gehlot PM, Manjunath V, et al. A comparative evaluation of advanced platelet-rich fibrin (A-PRF) and platelet-rich fibrin (PRF) as a scaffold in regenerative endodontic treatment of traumatized immature non-vital permanent anterior teeth: a prospective clinical study. J Clin Exp Dent 2021;13(5):e463–e472. DOI: 10.4317/jced.57902
  7. American Academy of Pediatric Dentistry. Guideline on pulp therapy for primary and immature permanent teeth. Pediatr Dent 2009;31:179–186.
  8. El-Khodary H, El-Ashiry E, El-Shehaby F, et al. Comparative study of CH and MTA used in apexogenesis for young first permanent molars. Curr Sci Int 2014;3(2):150–158.
  9. American Academy of Pediatric Dentistry. Clinical guidelines on pulp therapy for primary and young permanent teeth: reference manual 2006-07. Pediatr Dent 2006;28:144–148.
  10. Lv H, Chen Y, Cai Z, et al. The efficacy of platelet-rich fibrin as a scaffold in regenerative endodontic treatment: a retrospective controlled cohort study. BMC Oral Health 2018;18(1):139. DOI: 10.1186/s12903-018-0598-z
  11. Markowitz K, Moynihan M, Liu M, et al. Biologic properties of eugenol and zinc oxide-eugenol: a clinically oriented review. Oral Surg Oral Med Oral Pathol 1992;73(6):729–737. DOI: 10.1016/0030-4220(92)90020-q
  12. Johns DA, Varughese JM, Thomas K, et al. Clinical and radiographical evaluation of the healing of large periapical lesions using triple antibiotic paste, photo activated disinfection and calcium hydroxide when used as root canal disinfectant. J Clin Expe Dent 2014;6(3):e230–e236. DOI: 10.4317/jced.51324
  13. Sallam NM, El-Kalla IH, Wahba AH, et al. Clinical and radiographic evaluation of platelet-rich fibrin for revascularization of necrotic immature permanent teeth: a controlled clinical trial. Pediatr Dent J 2020;30(3):182–190. DOI: 10.1016/j.pdj.2020.09.001
  14. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2006;101(3):e45–e50. DOI: 10.1016/j.tripleo.2005.07.009
  15. Matsuo T, Nakanishi T, Shimizu H, et al. A clinical study of direct pulp capping applied to carious-exposed pulps. J Endod 1996;22(10):551–556. DOI: 10.1016/S0099-2399(96)80017-3
  16. Ward J. Vital pulp therapy in cariously exposed permanent teeth and its limitations. Australian Endod J 2002;28(1):29–37. DOI: 10.1111/j.1747-4477.2002.tb00364.x
  17. Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2006;101(3):e56–e60. DOI: 10.1016/j.tripleo.2005.07.011
  18. Bhavana V, Chaitanya KP, Gandi P, et al. Evaluation of antibacterial and antifungal activity of new calcium-based cement (biodentine) compared to MTA and glass ionomer cement. J Conserv Dent 2015;18(1):44–46. DOI: 10.4103/0972-0707.148892
  19. El-Sherbeiny M. Clinical, radiographic and histological assessment of MTA and calcium hydroxide apexification materials (Human and Animal study). Cairo Dent J 2003;19(2):185–191.
  20. El Meligy OA, Avery DR. Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis). Pediatr Dent 2006;28(5):399–404.
  21. Kumar V, Juneja R, Duhan J, et al. Comparative evaluation of platelet-rich fibrin, mineral trioxide aggregate, and calcium hydroxide as pulpotomy agents in permanent molars with irreversible pulpitis: a randomized controlled trial. Contemp Clin Dent 2016;7(4):512–518. DOI: 10.4103/0976-237X.194107
  22. Eid A, Mancino D, Rekab MS, et al. Effectiveness of three agents in pulpotomy treatment of permanent molars with incomplete root development: a randomized controlled trial. Healthcare 2022;10(3):431. DOI: 10.3390/healthcare10030431
  23. Sopariwala N, Garg S. Regenerative endodontic procedure using platelet-rich fibrin to treat traumatized immature permanent tooth: a case report. IOSR J Dent Med Sci 2015;14(5):36–40.
  24. Briso AL, Rahal V, Mestrener SR, et al. Biological response of pulps submitted to different capping materials. Brazilian Oral Res 2006;20(3):219–225. DOI: 10.1590/s1806-83242006000300007
  25. Chacko DV, Kurikose DS. Human pulpal response to mineral trioxide aggregate (MTA): a histologic study. J Clin Pediatr Dent 2006;30(3):203–209. DOI: 10.17796/jcpd.30.3.38h13g5p84651652
  26. Jabarifar SE, AA K, Ghasemi D. Success rate of formocresol pulpotomy versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci 2004;6(6):55–58.
  27. Percinoto C, De Castro AM, Pinto L. Clinical and radiographic evaluation of pulpotomies employing calcium hydroxide and trioxide mineral aggregate. Gen Dent 2006;54(4):258–261.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.